Bronislava Gedulin
Keine laufenden Positionen mehr
Profil
Bronislava Gedulin is the founder of Satiogen Pharmaceuticals, Inc. (founded in 2007) and Lumena Pharmaceuticals, Inc. (founded in 2011).
At Lumena Pharmaceuticals, Inc., she held the title of Vice President-Research & Development from 2011 to 2013.
Dr. Gedulin's former jobs include being a Principal Scientist at Amylin Pharmaceuticals, Inc. and a Professor at Latvijas Zinatnu akademija.
She holds a doctorate degree from Moscow University and Riga Stradinš University, and an undergraduate degree from the University of Latvia.
Ehemalige bekannte Positionen von Bronislava Gedulin
| Unternehmen | Position | Ende |
|---|---|---|
Satiogen Pharmaceuticals, Inc.
 Satiogen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Satiogen Pharmaceuticals, Inc. engages in the development of therapeutic treatments for diabetes and obesity. It offers a metabolic mechanism for treating diabetes and obesity without intervention by systemically absorbed pharmaceuticals or invasive surgical methods. The firm’s product strategies include non-absorbed ASBT inhibitor, non-surgical biliary shunt, rectal satiogen, non-absorbed TGR5 ligand and labile bile acid sequestrant. The company was founded by Andrew Young and Bronislava Gedulin in 2007 and is headquartered in Del Mar, CA. | Gründer | - |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Latvijas Zinatnu akademija
 Latvijas Zinatnu akademija Other Consumer ServicesConsumer Services Latvijas Zinatnu akademija is a Latvian academy of sciences that conducts research and publishes scientific articles. The academy is based in Riga, Latvia. The academy also has a newspaper called "Science Vestnesis" that is published electronically once a month, except for August. The academy hosts events such as the World Congress of Latvian Scientists, which focuses on topics such as digital transformation and green conversion. | Corporate Officer/Principal | - |
Lumena Pharmaceuticals, Inc.
 Lumena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lumena Pharmaceuticals, Inc. developed oral therapeutics for rare liver diseases. The firm was engaged in the development and commercialization of novel products for rare cholestatic liver diseases and serious metabolic disorders, such as nonalcoholic steatohepatitis. The company was founded by Bronislava Gedulin and Michael G. Grey in January 2011 and was headquartered in San Diego, CA. | Gründer | - |
Ausbildung von Bronislava Gedulin
| Moscow University | Doctorate Degree |
| Riga Stradinš University | Doctorate Degree |
| University of Latvia | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Lumena Pharmaceuticals, Inc.
Lumena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lumena Pharmaceuticals, Inc. developed oral therapeutics for rare liver diseases. The firm was engaged in the development and commercialization of novel products for rare cholestatic liver diseases and serious metabolic disorders, such as nonalcoholic steatohepatitis. The company was founded by Bronislava Gedulin and Michael G. Grey in January 2011 and was headquartered in San Diego, CA. | Health Technology |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
Latvijas Zinatnu akademija
Latvijas Zinatnu akademija Other Consumer ServicesConsumer Services Latvijas Zinatnu akademija is a Latvian academy of sciences that conducts research and publishes scientific articles. The academy is based in Riga, Latvia. The academy also has a newspaper called "Science Vestnesis" that is published electronically once a month, except for August. The academy hosts events such as the World Congress of Latvian Scientists, which focuses on topics such as digital transformation and green conversion. | Consumer Services |
Satiogen Pharmaceuticals, Inc.
Satiogen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Satiogen Pharmaceuticals, Inc. engages in the development of therapeutic treatments for diabetes and obesity. It offers a metabolic mechanism for treating diabetes and obesity without intervention by systemically absorbed pharmaceuticals or invasive surgical methods. The firm’s product strategies include non-absorbed ASBT inhibitor, non-surgical biliary shunt, rectal satiogen, non-absorbed TGR5 ligand and labile bile acid sequestrant. The company was founded by Andrew Young and Bronislava Gedulin in 2007 and is headquartered in Del Mar, CA. | Commercial Services |